17 Advanced Solid Tumors Clinical Trials in West Valley City, UT (2026)

Q: How do I join a clinical trial in West Valley City?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the West Valley City research site will contact you.

Recruiting Advanced Solid Tumors Studies in West Valley City

NCT06220864Recruiting

SNV1521 in Participants With Advanced Solid Tumors

This study is testing a new medicine, SNV1521, for people with advanced cancers. The researchers want to find out if SNV1521 is safe, well-tolerated, and effective in treating solid tumors. They are i...

West Valley City, UTPHASE1400 participantsSynnovation Therapeutics, Inc.

View Study Details

NCT06554795Recruiting

First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

A Phase 1/2a First-in-Human Study of DB-1419 in Advanced/Metastatic Solid Tumors...

West Valley City, UTPHASE1360 participantsDualityBio Inc.

View Study Details

NCT07160725Recruiting

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

A phase 1/2a, open-label, first-in-human study mainly aimed to evaluate the safety and tolerability of BMS-986517 in participants with solid tumors...

West Valley City, UTPHASE1315 participantsBristol-Myers Squibb

View Study Details

NCT07136779Recruiting

First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies

This is a multicenter, open-label, multiple-dose, FIH Phase 1/2a trial. The Phase 1 portion adopts an accelerated titration for the first dose level, followed by BOIN design to identify the MTD and/or...

West Valley City, UTPHASE1310 participantsVelaVigo Bio Inc

View Study Details

NCT07300943Recruiting

Study in Advanced Solid Tumor Patients

The study will be conducted in 2 phases: Phase 1: Dose-escalation and Dose Level Expansion, Phase 1 will determine the maximum tolerated dose (MTD) and/or recommended dose for expansion (RDE). Phase 2...

West Valley City, UTPHASE1306 participantsCallio Therapeutics

View Study Details

NCT06242470Recruiting

A Study of MGC026 in Participants With Advanced Solid Tumors

The study is designed to understand the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary antitumor activity of MGC026 in participants with relapsed or refractory, unresectable, ...

West Valley City, UTPHASE1250 participantsMacroGenics

View Study Details

NCT05985655Recruiting

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

The primary purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) and anti-tumor activity of GTAEXS617-001 in participants with advanced solid tumors....

West Valley City, UTPHASE1230 participantsExscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

View Study Details

NCT06577987Recruiting

Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

This is a first-in-human, multicenter, open-label, phase 1 study to evaluate safety, tolerability, and efficacy of CID-078, a Cyclin A/B-RxL inhibitor, in patients with advanced solid tumors....

West Valley City, UTPHASE1220 participantsCircle Pharma

View Study Details

NCT07266428Recruiting

A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

The main goals of this clinical trial are to find out what the best dose of the study drug, OTP-01, is for patients with solid tumors through understanding how it is tolerated and any side effects tha...

West Valley City, UTPHASE1170 participantsOttimo Pharma Limited

View Study Details

NCT07145255Recruiting

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

This is a multicenter, open-label FIH, Phase 1a (dose escalation), Phase 1b (dose expansion) and Phase 2 study in patients with advanced metastatic solid tumors refractory to standard treatment....

West Valley City, UTPHASE1150 participantsMBrace Therapeutics

View Study Details

NCT06723236Recruiting

A Study of MGC028 in Participants With Advanced Solid Tumors

The goal of this clinical trial is to characterize the safety, tolerability, dose-limiting toxicities (DLT), and maximum tolerated dose (MTD) or maximum administered dose of MGC028 (if no MTD is defin...

West Valley City, UTPHASE1124 participantsMacroGenics

View Study Details

NCT06797336Recruiting

A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors

The primary purpose of this study is to evaluate the safety and tolerability, determine the maximally tolerated dose (MTD) and/or recommended Phase 2 dose(s) (RP2D) of PT0253 in adult participants wit...

West Valley City, UTPHASE1115 participantsPAQ Therapeutics, Inc.

View Study Details

NCT07361562Recruiting

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

This is an open-label, phase 1/1b study evaluating the safety, tolerability, pharmacokinetic (what the body does to the drug), pharmacodynamic (what the drug does to the body), and antitumor activity ...

West Valley City, UTPHASE1100 participantsCogent Biosciences, Inc.

View Study Details

NCT06833008Recruiting

A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours

The purpose of this study is to determine the appropriate dosage, safety and effectiveness of a new study drug IPN01195 in adults with advanced solid tumours. The participants in this study will have...

West Valley City, UTPHASE185 participantsIpsen

View Study Details

NCT06710379Recruiting

A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors

The primary purpose of this study is to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0405 in patients with select advanced solid tumors....

West Valley City, UTPHASE168 participantsAdcentrx Therapeutics

View Study Details

NCT07517198Recruiting

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

The primary purpose of this study is to determine the safety, tolerability, and maximum tolerated dose (MTD) of EXS74539 (REC-4539) in participants with select solid tumors....

West Valley City, UTPHASE140 participantsExscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

View Study Details

NCT06801002Recruiting

Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies

This will be a phase 1, open-label, dose-escalation and expansion, FIH trial to evaluate the safety, tolerability, PK, PD, and preliminary efficacy of JBZ-001, a DHODH inhibitor, in patients with refr...

West Valley City, UTPHASE125 participantsJabez Bioscience, Inc

View Study Details

About Advanced Solid Tumors Clinical Trials in West Valley City

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 17 advanced solid tumors clinical trials recruiting participants in West Valley City, UT. These studies are seeking a combined 3,268 participants. Research is being sponsored by Synnovation Therapeutics, Inc., DualityBio Inc., Bristol-Myers Squibb and 12 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in West Valley City — FAQ

Are there advanced solid tumors clinical trials in West Valley City?

Yes, there are 17 advanced solid tumors clinical trials currently recruiting in West Valley City, UT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in West Valley City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the West Valley City research site will contact you about next steps.

Are clinical trials in West Valley City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many West Valley City studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 17 active trials in West Valley City are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated July 22, 2026 from ClinicalTrials.gov